Ashland (ASH) Q1 2026 Earnings Call Summary

1Key Financial Results and Metrics

Sales: $386 million, down 5% year-over-year (YoY). Excluding the Evoqua divestiture, sales declined 3%.

Adjusted EBITDA: $58 million, down 5% YoY; adjusted EBITDA margin held steady at 15%.

Adjusted EPS: $0.26, down 7% YoY.

Free Cash Flow: $26 million, with operating cash flow of $125 million and a healthy free cash flow conversion of nearly 50%.

Net Debt: $1.1 billion, with a net leverage ratio of 2.7 times.

Liquidity: Approximately $900 million available.

2Strategic Updates and Business Highlights

Life Sciences: Sales grew 4% YoY, driven by resilient pharma demand and innovation in high-value cellulosic excipients and injectables.

Personal Care: Stable performance with underlying demand; biofunctional actives grew double digits. However, unplanned customer outages impacted core hair and skin care sales.

Specialty Additives: Sales down 11% YoY, primarily due to weakness in coatings and construction, particularly in China.

Operational Efficiency: Continued focus on cost discipline and productivity improvements, with a total cost savings target of $30 million for fiscal 2026.

Innovation: Strong momentum in new product launches across all segments, particularly in Life Sciences and Personal Care.

3Forward Guidance and Outlook

Fiscal 2026 Adjusted EBITDA Guidance: Narrowed to $400 million to $420 million, reflecting cautious optimism amid mixed market conditions.

Recovery Expectations: Anticipated recovery from customer outages and operational disruptions in the second half of the fiscal year.

Market Conditions: Life Sciences and Personal Care expected to remain resilient, while Specialty Additives and Intermediates face mixed demand.

4Bad News, Challenges, or Points of Concern

Volume Declines: Specialty Additives and Intermediates faced significant volume declines due to weak demand, particularly in coatings and construction.

Operational Disruptions: Equipment issues at the Calvert City facility are extending into Q2, impacting margins and operational efficiency.

Market Headwinds: Ongoing softness in coatings and construction markets, particularly in China, with overcapacity and competitive pressures persisting.

Pricing Pressures: Modest pricing declines across segments, reflecting carryover adjustments from the prior year.

5Notable Q&A Insights

Customer Outages: Personal Care experienced temporary customer outages impacting demand, but recovery is expected in Q2 and throughout the year.

Demand Recovery: Management expressed cautious optimism about demand recovery in the second quarter, with a strong order book for February.

China Coatings Demand: Management indicated that while the coatings market in China remains challenging, they expect to see improvements in the second half of the fiscal year.

Long-term Growth: Focus on innovation and productivity improvements is seen as crucial for rebuilding EBITDA to higher levels as market conditions stabilize. Overall, Ashland's Q1 2026 results reflect a mixed performance across its business segments, with strategic initiatives in innovation and operational efficiency aimed at navigating current challenges and positioning for future growth.